Insulet slips 2.5% pre-market on JMP downgrade

|About: Insulet Corporation (PODD)|By:, SA News Editor

Shares of Insulet (PODD) slip 2.5% pre-market after JMP Securities downgrades the insulin device manufacturer to Perform from Outperform, citing increased reports in the FDA's MAUDE database, negative customer feedback online, and higher-than-expected failure rates.